Evidence map›Paper›PMID 42264506›Full record

ArticleBMJ global health2026

Family planning exemplar country selection methodology: time lag and trends analysis.

Zahid Ali Memon, Abeer Mian, Ira Martopullo, Narjis Fatima Hussain, Zeba Sathar, Ali Mohammad Mir, Michael Mbizvo, Marleen Temmerman, Jen Kidwell Drake, Zulfiqar A Bhutta

Abstract read
In one paragraph

Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zahid Ali MemonCommunity Health Sciences, The Aga Khan University, Karachi, Pakistan zahid.memon@aku.edu.ORCID 0000-0002-5321-8885
Abeer MianCommunity Health Sciences, The Aga Khan University, Karachi, Pakistan.ORCID 0000-0002-1650-5754
Ira MartopulloGates Ventures LLC, Seattle, Washington, USA.ORCID 0000-0002-8715-2335
Narjis Fatima HussainCentre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0001-8616-8194
Zeba SatharPopulation Council Pakistan Office, Islamabad, Pakistan.ORCID 0000-0002-0068-9923
Ali Mohammad MirPopulation Council Pakistan Office, Islamabad, Pakistan.ORCID 0000-0001-8613-1228
Michael MbizvoPopulation Council Zambia, Lusaka, Zambia.ORCID 0000-0001-8262-8640
Marleen TemmermanCentre of Excellence in Women and Child Health, The Aga Khan University Hospital Nairobi, Nairobi, Kenya.ORCID 0000-0003-2069-8752
Jen Kidwell DrakeGates Ventures LLC, Seattle, Washington, USA.
Zulfiqar A BhuttaCentre for Global Child Health, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-0637-599X

Funding

the Bill & Melinda Gates Foundation INV-024094
6 · The paper itself

Abstract

introductionWhile many countries achieved notable gains in contraceptive use levels after the 1994 International Conference on Population and Development which redefined family planning (FP) as a human right, there was a long period of 15 years when contraceptive use levels did not receive due attention. It was only later that its subsequent inclusion in the Sustainable Development Goals and the 2012 London Summit on FP renewed global commitment and a focus towards FP. This paper aims to select countries that identify as 'exemplar' low-middle-income countries that have achieved exceptional progress in FP. Examining these outliers can uncover actionable drivers of success to accelerate progress in other countries that have not achieved as much success and are still experiencing stagnation in contraceptive prevalence rates.

methodsWe selected exemplar countries based on exceptional performance across the outcome indicators of modern contraceptive prevalence and demand satisfied for modern methods, using a recent time frame post 2000 when focus on improving FP returned to the field. A selection approach was applied across various time periods to assess change in modern contraceptive prevalence rates (mCPR) and demand satisfied as the dependent variables. The Human Development Index for 2015 was used as a predictor of contraceptive use on a pooled sample of 130 countries.

resultsThe countries, defined by our criteria of residuals falling much higher than expected levels of predicted mCPR at a high level of significance, fell in the African continent. The countries selected in the first round were Senegal, Malawi, Kenya based on deviation from the predicted pattern at 5% significance level. In the second round, Sierra Leone from the African region, Lao People's Democratic Republic from Asia and Bolivia from Latin America, were added, on relaxing the level of significance, but still using the same approach. This was to have comparators in different regions.

conclusionsOur methodology, using a time lag analysis to build in an element of causation, offers a novel approach to selecting exemplar countries in family planning, based on the Human Development Index as a control metric.

Indexed as

ContraceptionContraception BehaviorDeveloping CountriesFamily Planning ServicesFemaleHumansTime FactorsGlobal HealthPublic Health

Identifiers

PMID42264506
PMCPMC13250220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.